|
KLHL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.55379994928973E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.91270005284383E-09 |
| Normal-vs-Stage2 |
1.296170E-02 |
| Normal-vs-Stage3 |
2.6948999998222E-07 |
| Normal-vs-Stage4 |
7.326000E-02 |
| Stage1-vs-Stage2 |
3.387800E-01 |
| Stage1-vs-Stage3 |
7.061600E-01 |
| Stage1-vs-Stage4 |
3.813000E-01 |
| Stage2-vs-Stage3 |
2.601400E-01 |
| Stage2-vs-Stage4 |
9.007400E-01 |
| Stage3-vs-Stage4 |
2.453000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.0303985683372E-11 |
| Normal-vs-AfricanAmerican |
3.151200E-04 |
| Normal-vs-Asian |
5.775400E-04 |
| Caucasian-vs-AfricanAmerican |
1.365570E-01 |
| Caucasian-vs-Asian |
8.705800E-01 |
| AfricanAmerican-vs-Asian |
5.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.90239992834552E-10 |
| Normal-vs-Female |
2.01980000003044E-06 |
| Male-vs-Female |
1.806770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.56629997439506E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.261500E-03 |
| Normal-vs-Extreme_Obese |
7.029300E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.866600E-01 |
| Normal_Weight-vs-Obese |
6.587600E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.458200E-01 |
| Extreme_Weight-vs-Obese |
6.000700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.753200E-01 |
| Obese-vs-Extreme_Obese |
5.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.211000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.60540000024601E-07 |
| Normal-vs-Age(61-80Yrs) |
1.77635683940025E-15 |
| Normal-vs-Age(81-100Yrs) |
1.42830000005034E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.087620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.285040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.440240E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.528400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.80229958629741E-10 |
| Normal-VS-Type2 PRCC |
3.06360492530189E-11 |
| Normal-VS-KIRP CIMP |
8.309800E-01 |
| Normal-VS-Unclassified PRCC |
1.855650E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.536600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.654400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.853000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.756200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.933830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.474000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.85170023548187E-10 |
| Normal-vs-N1 |
1.427360E-04 |
| Normal-vs-N2 |
3.259600E-01 |
| N0-vs-N1 |
1.532230E-01 |
| N0-vs-N2 |
7.034200E-01 |
| N1-vs-N2 |
9.726800E-01 |
|
|
